"
Template:SupbiotechparisFr
From 2009.igem.org
(Difference between revisions)
Enguerrand (Talk | contribs) |
Enguerrand (Talk | contribs) |
||
| Line 62: | Line 62: | ||
[[Team:SupBiotech-Paris/Thérapies actuelles|Thérapies actuelles]] | [[Team:SupBiotech-Paris/Thérapies actuelles|Thérapies actuelles]] | ||
[[Team:SupBiotech-Paris/Thérapies géniques|Thérapies géniques]] | [[Team:SupBiotech-Paris/Thérapies géniques|Thérapies géniques]] | ||
| - | <span style="color: black;">'''DVS'''</span> | + | <span style="color: black;">'''Concept DVS'''</span> |
[[Team:SupBiotech-Paris/Introduction1Fr|Introduction]] | [[Team:SupBiotech-Paris/Introduction1Fr|Introduction]] | ||
[[Team:SupBiotech-Paris/Concept1Fr|Ciblage Tissulaire]] | [[Team:SupBiotech-Paris/Concept1Fr|Ciblage Tissulaire]] | ||
Revision as of 11:49, 21 September 2009
Projet
Introduction Thérapies actuelles Thérapies géniques Concept DVS Introduction Ciblage Tissulaire Ciblage Cellulaire Plasmide d'apoptose Conclusion Mise en application Ciblage Tissulaire Ciblage Cellulaire Modélisation cancer Conclusion
Ressources
Biobricks Matériel & Méthode Bibliographie
Ethique & sûreté
Biologie Synthetique Notre projet Sûreté
